Back to search

Article

AI-guided design of a CXCR4-targeted core–shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapy

2025-08-14

Abstract excerpt

<title>Abstract</title> <p>An integrated three-step artificial-intelligence (AI) workflow was used to accelerate the design of a CXCR4-targeted, dual-drug nanocarrier for colorectal-cancer therapy. First, the MD-Syn platform screened 38 approved oncology agents across six human colorectal-cancer cell lines (HCT116, HT29, LoVo, RKO, SW620, SW837) and identified paclitaxel (PTX) as the compound with a > 0.9999 prob...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db623cfe-30df-5177-957b-4fbc23cdf546
DOI
10.21203/rs.3.rs-7307122/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AI-guided design of a CXCR4-targeted core–shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapyDOI 10.21203/rs.3.rs-7307122/v1
Select a neighboring publication to make it the new centre.